ENTPD1 and head and neck cancer: It was reported recently that co-expression of CD39 and CD103 identifies a unique population of CD8 TILs that can only be found within the tumor microenvironment, and higher frequencies of CD103+CD39+ CD8 TILs in patients with head and neck cancer are associated with better overall survival [22].